Analysis Decisions on WHO’s essential medicines need more scrutiny BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4798 (Published 31 July 2014) Cite this as: BMJ 2014;349:g4798 Article Related content Metrics Responses Peer review Related articles Analysis Commentary: Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health Published: 31 July 2014; BMJ 349 doi:10.1136/bmj.g4823 Editor's Choice Essential fruit, vegetables, and lists for health Published: 31 July 2014; BMJ 349 doi:10.1136/bmj.g4906 Letter The composition of WHO’s expert committee on essential medicines needs more scrutiny Published: 19 August 2014; BMJ 349 doi:10.1136/bmj.g5211 AnalysisCommentaryPodcastCorrado Barbui discusses the list in The BMJ podcast See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265
